| 000 | 01008 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515114604.0 | ||
| 264 | 0 | _c20080912 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/s0149-2918(08)80037-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMehta, Atul | |
| 245 | 0 | 0 |
_aFabry disease--whom to treat and when. _h[electronic resource] |
| 260 |
_bClinical therapeutics _c2008 |
||
| 300 |
_aS43-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 |
_aFabry Disease _xcomplications |
| 650 | 0 | 4 | _aFamily |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xtherapeutic use |
| 650 | 0 | 4 |
_aMutation, Missense _xgenetics |
| 650 | 0 | 4 |
_aalpha-Galactosidase _xtherapeutic use |
| 773 | 0 |
_tClinical therapeutics _gvol. 30 Suppl B _gp. S43-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0149-2918(08)80037-9 _zAvailable from publisher's website |
| 999 |
_c17893963 _d17893963 |
||